Jennifer Jo Thompson
University of Georgia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jennifer Jo Thompson.
Culture, Medicine and Psychiatry | 2009
Jennifer Jo Thompson; Cheryl Ritenbaugh; Mark Nichter
This paper considers how the full range of human experience may catalyze a placebo response. The placebo effect has been characterized as something to control in clinical research, something to cultivate in clinical practice and something present in all healing encounters. We examine domains in which the term ‘placebo’ is used in discourse: clinical research, clinical practice, media representations of treatment efficacy and lay interpretations of placebo—an underresearched topic. We briefly review major theoretical frameworks proposed to explain the placebo effect: classical conditioning, expectancy, the therapeutic relationship and sociocultural ‘meaning.’ As a corrective to what we see as an overemphasis on conscious cognitive approaches to understanding placebo, we reorient the discussion to argue that direct embodied experience may take precedence over meaning-making in the healing encounter. As an example, we examine the neurobiology of rehearsing or visualizing wellness as a mode of directly (performatively) producing an outcome often dismissed as a ‘placebo response.’ Given body/mind/emotional resonance, we suggest that the placebo response is an evolutionarily adaptive trait and part of healing mechanisms operating across many levels—from genetic and cellular to social and cultural.
Health Education & Behavior | 2007
Mimi Nichter; Mark Nichter; Myra L. Muramoto; Shelly Adrian; Kate Goldade; Laura Tesler; Jennifer Jo Thompson
This article presents findings from a qualitative study of 53 low-income women who were smokers at the onset of pregnancy. Study participants were interviewed during pregnancy to document smoking trajectories and factors contributing to, or undermining, harm reduction and quit attempts. Thirty percent of women quit smoking completely, 43% engaged in sustained harm reduction, and 26% reduced their smoking levels intermittently. Case studies of women are presented to illustrate reasons for quitting, harm reduction practices, and factors influencing relapse and smoking continuation. Womens motivations to quit are highlighted. Moral identity as a mother was found to be a key motivating factor behind womens quit attempts. Future programs targeting this population would do well to acknowledge moral identity as an issue and recognize the challenges of quitting for women with limited social support and little control over their immediate environment.
Medical Anthropology Quarterly | 2016
Jennifer Jo Thompson; Mark Nichter
Chronic conditions associated with lifestyle and modifiable behaviors are the leading causes of morbidity and mortality in the United States. The implementation of the Affordable Care Act offers an historic opportunity to consider novel approaches to addressing the nations public health concerns. We adopt an anticipatory anthropological perspective to consider lifestyle behavior change as common ground shared by practitioners of both biomedicine and common forms of complementary and alternative medicine (CAM). At issue is whether CAM practitioners might play a more proactive and publicly endorsed role in delivering preventive and promotive health services to address these needs. Recognizing that this is a contentious issue, we consider two constructive roles for engaged medical anthropologists: (1) as culture brokers helping to facilitate interprofessional communities of preventive and promotive health practice and (2) in collaboration with health service researchers developing patient-near evaluations of preventive and promotive health services on patient well-being and behavior change.
Precision Agriculture | 2018
Chase M. Straw; Gerald M. Henry; Jerry Shannon; Jennifer Jo Thompson
Natural turfgrass sports field properties exhibit within-field variations due to foot traffic from play, field construction, management, and weather. Little is known about the influences these variations may have on athletes’ perceptions of field playability and injury risk. Information regarding athletes’ perceptions of within-field variability could be fundamental for identifying key surface properties important to athletes, which may also be useful for the progression and implementation of Precision Turfgrass Management on sports fields. A case study using mixed methods was conducted on a recreational-level turfgrass sports field to better understand athletes’ perceptions of within-field variability. Geo-referenced normalized difference vegetation index, surface hardness, and turfgrass shear strength data were obtained to create hot spot maps for identification of significant within-field variations. Walking interviews were conducted in situ with 25 male and female collegiate Club Sports rugby and ultimate frisbee athletes to develop knowledge about athletes’ perceptions of within-field variability. Field data, hot spot maps, and walking interview responses were triangulated to explore, compare, and validate findings. Athletes’ perceptions of within-field variability generally corresponded with measured surface properties. Athletes perceived within-field variations of turfgrass coverage and surface evenness to be most important. They expressed awareness of potential influences the variations could have, but not all athletes made behavior changes. Those who reported changing did so with regard to athletic maneuvers and/or strategy, primarily for safety or context of play. Spatial maps of surface properties that athletes identified could be used for Precision Turfgrass Management to potentially improve perceptions by mitigating within-field variability.
BMC Women's Health | 2017
Jennifer Jo Thompson; Cheryl Ritenbaugh; Mark Nichter
BackgroundIn recent years, compounded bioidentical hormone therapy (CBHT) has emerged as a popular alternative to manufactured, FDA approved hormone therapy (HT)—despite concerns within the medical community and the availability of new FDA approved “bioidentical” products. This study aims to characterize the motivations for using CBHT in a U.S. sample of ordinary midlife women.MethodsWe analyze data collected from 21 current and former users of CBHT who participated in a larger qualitative study of menopausal decision-making among U.S. women. Interviews and focus groups were audio-recorded, transcribed verbatim, and analyzed thematically using an iterative inductive and deductive process.ResultsAlthough women’s individual motivations varied, two overarching themes emerged: “push motivations” that drove women away from conventional HT and from alternative therapies, and “pull motivations” that attracted women to CBHT. Push motivations focused on (1) fear and uncertainty about the safety of conventional HT, (2) an aversion to conjugated estrogens in particular, and (3) and overarching distrust of a medical system perceived as dismissive of their concerns and overly reliant on pharmaceuticals. Participants also voiced dissatisfaction with the effectiveness of herbal and soy supplements. Participants were attracted to CBHT because they perceive it to be (1) effective in managing menopausal symptoms, (2) safer than conventional HT, (3) tailored to their individual bodies and needs, and (4) accompanied by enhanced clinical care and attention.ConclusionsThis study finds that women draw upon a range of “push” and “pull” motivations in their decision to use CBHT. Importantly, we find that women are not only seeking alternatives to conventional pharmaceuticals, but alternatives to conventional care where their menopausal experience is solicited, their treatment goals are heard, and they are engaged as agents in managing their own menopause. The significance of this finding goes beyond understanding why women choose CBHT. Women making menopause treatment decisions of all kinds would benefit from greater shared decision-making in the clinical context in which they are explicitly invited to share their experiences, priorities, and preferences. This would also provide an opportunity for clinicians to discuss the pros and cons of conventional HT, CBHT, and other approaches to managing menopause.
Culture, Medicine and Psychiatry | 2006
Mark Nichter; Jennifer Jo Thompson
Medical Anthropology Quarterly | 2014
Sarah Horton; César Ernesto Abadía; Jessica Mulligan; Jennifer Jo Thompson
BMC Complementary and Alternative Medicine | 2011
Jennifer Jo Thompson; Kimberly L Kelly; Cheryl Ritenbaugh; Allison L. Hopkins; Colette Sims; Stephen Joel Coons
Alternative Therapies in Health and Medicine | 2007
Jennifer Jo Thompson; Mark Nichter
Agriculture and Human Values | 2017
Jennifer Jo Thompson; A. June Brawner; Usha Kaila